{
  "main_header": {
    "sid": 469937,
    "name": "Themis Medicare",
    "stock_name": "Themis Medicare",
    "full_name": "Themis Medicare Ltd",
    "name_url": "stocks-analysis/themis-medicare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "101.60",
    "chg": -1.85,
    "chgp": "-1.79%",
    "dir": -1,
    "prev_price": "103.45",
    "mcapval": "944.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530199,
    "symbol": "THEMISMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083B01024",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "46.84 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/themis-medicare-469937-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 245,
    "sid": "469937",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/themis-medicare-469937"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance Report for the financial year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-May-2026",
      "details": "Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 28Th May 2026",
      "datetime": "28-May-2026",
      "details": "1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 together with the Report issued by the Statutory Auditors M/s. Krishaan & Co. Chartered Accountants which are attached herewith. 2. Recommended final dividend of Re. 0.50 i.e. @ 50 % per equity share having face value of Re.1/- each aggregating to Rs. 46050060 /- for the Financial Year ended 31st March 2026 subject to the approval of shareholders at the forthcoming Annual General Meeting. 3. Appointment of M/s. R. Nanabhoy & Co. Cost Accountants (FRN - 000011) as the Cost Auditor of the Company for the Financial Year Financial Year 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Oct 23",
          "dt": "2023-10-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News